TrialClinical drug investigation2022

Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects.

Mikkel Askjær Agersnap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.